CSL Behring Asia Pacific Limited

Yes. CSL Behring Asia Pacific Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2000-03-06 (operating for 26 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: November 2026).

The statutory primary identifiers for CSL Behring Asia Pacific Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [30914106] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [0706692] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. According to the official statutory records of the Hong Kong Companies Registry, CSL Behring Asia Pacific Limited has officially recorded 5 legal name change(s): [ORIENT FIRST VENTURE LIMITED (effective 2000-03-06)], [AVENTIS BEHRING ASIA PACIFIC LIMITED (effective 2000-05-08)], [AVENTIS BEHRING ASIA PACIFIC LIMITED (安萬特貝林(亞太區)有限公司) (effective 2001-04-17)], [ZLB Behring Asia Pacific Limited (傑特貝林(亞太區)有限公司) (effective 2004-09-17)], [CSL BIOTHERAPIES ASIA PACIFIC LIMITED (傑特生物醫療(亞太區)有限公司) (effective 2006-12-08)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Yes. Statutory indexing confirms that CSL Behring Asia Pacific Limited has accumulated 50 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-04-28: Form ND2A - Notice of Change of Company Secretary and Director (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

The statutory registered office of CSL Behring Asia Pacific Limited on official record is situated at: [ROOM 3806, 38/F, CENTRAL PLAZA, 18 HARBOUR ROAD, WAN CHAI, HONG KONG]. Official registry dossiers also record 3 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.